Francine Lee Jacobson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 31 | 2024 | 13382 | 1.820 |
Why?
|
| Solitary Pulmonary Nodule | 6 | 2023 | 279 | 1.370 |
Why?
|
| Early Detection of Cancer | 12 | 2023 | 3196 | 1.200 |
Why?
|
| Tomography, X-Ray Computed | 42 | 2023 | 20600 | 1.170 |
Why?
|
| Thoracic Surgical Procedures | 5 | 2017 | 350 | 0.870 |
Why?
|
| Radiography, Thoracic | 9 | 2017 | 1303 | 0.830 |
Why?
|
| Unnecessary Procedures | 2 | 2017 | 417 | 0.780 |
Why?
|
| Smoking | 10 | 2024 | 9055 | 0.590 |
Why?
|
| Medical Informatics Applications | 3 | 2013 | 179 | 0.570 |
Why?
|
| Visual Perception | 5 | 2013 | 1385 | 0.520 |
Why?
|
| Mass Chest X-Ray | 1 | 2015 | 18 | 0.520 |
Why?
|
| Mass Screening | 7 | 2016 | 5425 | 0.430 |
Why?
|
| Hernia | 1 | 2012 | 68 | 0.400 |
Why?
|
| Tobacco Use Cessation | 1 | 2013 | 94 | 0.400 |
Why?
|
| Splenic Diseases | 1 | 2012 | 91 | 0.390 |
Why?
|
| Diagnostic Errors | 3 | 2013 | 1265 | 0.390 |
Why?
|
| Hernia, Abdominal | 1 | 2012 | 56 | 0.380 |
Why?
|
| Mediastinal Emphysema | 2 | 2010 | 29 | 0.360 |
Why?
|
| Physical Examination | 1 | 2017 | 1255 | 0.360 |
Why?
|
| Diving | 3 | 2009 | 43 | 0.360 |
Why?
|
| Gallbladder Diseases | 1 | 2012 | 139 | 0.360 |
Why?
|
| Lung Diseases | 3 | 2015 | 1909 | 0.330 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 2000 | 0.320 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2012 | 285 | 0.320 |
Why?
|
| Outpatients | 1 | 2017 | 1596 | 0.320 |
Why?
|
| Primary Prevention | 2 | 2013 | 1185 | 0.310 |
Why?
|
| Smoking Cessation | 3 | 2021 | 2057 | 0.310 |
Why?
|
| Diagnostic Imaging | 5 | 2013 | 3535 | 0.300 |
Why?
|
| Lung | 13 | 2020 | 9979 | 0.300 |
Why?
|
| Preoperative Care | 1 | 2017 | 2242 | 0.300 |
Why?
|
| Postoperative Complications | 6 | 2021 | 15634 | 0.280 |
Why?
|
| Nephrectomy | 1 | 2012 | 938 | 0.280 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 8 | 2018 | 3200 | 0.280 |
Why?
|
| Technology, Radiologic | 2 | 2007 | 160 | 0.280 |
Why?
|
| Biomedical Research | 2 | 2019 | 3429 | 0.270 |
Why?
|
| Man-Machine Systems | 1 | 2006 | 42 | 0.270 |
Why?
|
| Insufflation | 1 | 2006 | 63 | 0.260 |
Why?
|
| Artificial Intelligence | 2 | 2023 | 2577 | 0.260 |
Why?
|
| Multiple Pulmonary Nodules | 3 | 2020 | 173 | 0.260 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2022 | 5318 | 0.260 |
Why?
|
| Data Display | 1 | 2006 | 175 | 0.250 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 4 | 2013 | 1223 | 0.250 |
Why?
|
| Radiology Information Systems | 3 | 2011 | 529 | 0.250 |
Why?
|
| Image Enhancement | 4 | 2010 | 2888 | 0.240 |
Why?
|
| American Cancer Society | 1 | 2024 | 69 | 0.240 |
Why?
|
| Pneumothorax | 3 | 2014 | 386 | 0.220 |
Why?
|
| Radiology | 3 | 2013 | 2114 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 5 | 2020 | 7400 | 0.210 |
Why?
|
| Humans | 84 | 2024 | 761098 | 0.200 |
Why?
|
| Health Promotion | 1 | 2013 | 2205 | 0.190 |
Why?
|
| Gallium Radioisotopes | 1 | 2022 | 195 | 0.180 |
Why?
|
| User-Computer Interface | 2 | 2011 | 1395 | 0.180 |
Why?
|
| Laparoscopy | 1 | 2012 | 2030 | 0.180 |
Why?
|
| Pneumonectomy | 2 | 2021 | 1118 | 0.170 |
Why?
|
| Pleural Neoplasms | 3 | 2010 | 609 | 0.160 |
Why?
|
| Anastomotic Leak | 1 | 2020 | 163 | 0.160 |
Why?
|
| Heredity | 1 | 2019 | 148 | 0.160 |
Why?
|
| Hospitals, Community | 1 | 2021 | 365 | 0.150 |
Why?
|
| Calcinosis | 2 | 2018 | 1477 | 0.150 |
Why?
|
| Risk Assessment | 7 | 2020 | 24013 | 0.150 |
Why?
|
| Neoplasm Staging | 6 | 2022 | 11118 | 0.140 |
Why?
|
| Aged | 29 | 2022 | 169266 | 0.140 |
Why?
|
| Clinical Trials as Topic | 2 | 2012 | 8000 | 0.140 |
Why?
|
| Thymectomy | 1 | 2017 | 195 | 0.140 |
Why?
|
| Radiation Dosage | 4 | 2012 | 1966 | 0.140 |
Why?
|
| Pulmonary Emphysema | 4 | 2014 | 683 | 0.130 |
Why?
|
| Esophagectomy | 1 | 2020 | 469 | 0.130 |
Why?
|
| Age Factors | 5 | 2019 | 18385 | 0.130 |
Why?
|
| Tracheal Diseases | 2 | 2008 | 118 | 0.130 |
Why?
|
| Bronchial Diseases | 2 | 2008 | 150 | 0.130 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2022 | 2025 | 0.130 |
Why?
|
| Thymoma | 1 | 2017 | 188 | 0.130 |
Why?
|
| Middle Aged | 32 | 2022 | 220835 | 0.130 |
Why?
|
| Female | 42 | 2024 | 392458 | 0.120 |
Why?
|
| Patient Selection | 3 | 2018 | 4245 | 0.120 |
Why?
|
| Thymus Neoplasms | 1 | 2017 | 274 | 0.120 |
Why?
|
| Male | 39 | 2023 | 360675 | 0.120 |
Why?
|
| Risk Factors | 16 | 2024 | 74219 | 0.120 |
Why?
|
| Esophagus | 1 | 2020 | 1033 | 0.110 |
Why?
|
| Radiography | 7 | 2013 | 6975 | 0.110 |
Why?
|
| Respiratory Mechanics | 2 | 2009 | 699 | 0.110 |
Why?
|
| Amphotericin B | 1 | 2014 | 142 | 0.110 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 15308 | 0.110 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2006 | 3367 | 0.110 |
Why?
|
| Cartilage Diseases | 1 | 1995 | 157 | 0.110 |
Why?
|
| Eye Movements | 2 | 2013 | 511 | 0.110 |
Why?
|
| Pedigree | 2 | 2019 | 4537 | 0.110 |
Why?
|
| Positron-Emission Tomography | 4 | 2022 | 6585 | 0.100 |
Why?
|
| Electrocoagulation | 1 | 1993 | 152 | 0.100 |
Why?
|
| Mesothelioma | 2 | 2010 | 807 | 0.100 |
Why?
|
| Community Health Services | 1 | 2017 | 654 | 0.100 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2012 | 65 | 0.100 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2011 | 59 | 0.090 |
Why?
|
| Thoracic Neoplasms | 1 | 1994 | 268 | 0.090 |
Why?
|
| Advisory Committees | 2 | 2012 | 788 | 0.090 |
Why?
|
| Patient Advocacy | 1 | 2013 | 359 | 0.090 |
Why?
|
| Surgery Department, Hospital | 1 | 2012 | 176 | 0.090 |
Why?
|
| Observer Variation | 5 | 2012 | 2611 | 0.090 |
Why?
|
| Utilization Review | 1 | 2012 | 382 | 0.090 |
Why?
|
| Thoracic Diseases | 1 | 2011 | 99 | 0.090 |
Why?
|
| Pattern Recognition, Visual | 2 | 2013 | 824 | 0.090 |
Why?
|
| Canada | 2 | 2012 | 2125 | 0.090 |
Why?
|
| Thoracic Injuries | 1 | 1992 | 288 | 0.080 |
Why?
|
| Length of Stay | 2 | 2021 | 6420 | 0.080 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 2 | 2006 | 89 | 0.080 |
Why?
|
| Thoracic Wall | 1 | 2011 | 202 | 0.080 |
Why?
|
| Emphysema | 1 | 2012 | 238 | 0.080 |
Why?
|
| Aircraft | 1 | 2010 | 130 | 0.080 |
Why?
|
| Awareness | 1 | 2013 | 649 | 0.080 |
Why?
|
| Body Burden | 1 | 2009 | 158 | 0.080 |
Why?
|
| Inhalation | 1 | 2009 | 143 | 0.080 |
Why?
|
| Geriatric Assessment | 1 | 2016 | 1409 | 0.080 |
Why?
|
| Triazoles | 1 | 2014 | 903 | 0.080 |
Why?
|
| Exhalation | 1 | 2009 | 182 | 0.080 |
Why?
|
| Sex Factors | 2 | 2019 | 10552 | 0.070 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2011 | 411 | 0.070 |
Why?
|
| Xenon Isotopes | 1 | 2007 | 67 | 0.070 |
Why?
|
| Aged, 80 and over | 11 | 2022 | 58946 | 0.070 |
Why?
|
| United States | 8 | 2024 | 72337 | 0.070 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 302 | 0.070 |
Why?
|
| Pulmonary Embolism | 4 | 2009 | 2571 | 0.070 |
Why?
|
| Pleural Diseases | 1 | 2008 | 137 | 0.070 |
Why?
|
| Biopsy, Needle | 2 | 2009 | 1624 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2011 | 36418 | 0.070 |
Why?
|
| Survival Rate | 1 | 2021 | 12727 | 0.070 |
Why?
|
| Coronary Vessels | 1 | 2018 | 3111 | 0.070 |
Why?
|
| Phlebography | 1 | 2008 | 326 | 0.070 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 2757 | 0.070 |
Why?
|
| Mouth | 1 | 2009 | 381 | 0.070 |
Why?
|
| Pharynx | 1 | 2009 | 432 | 0.070 |
Why?
|
| Comorbidity | 4 | 2016 | 10514 | 0.060 |
Why?
|
| Thoracic Surgery | 1 | 2012 | 722 | 0.060 |
Why?
|
| Proteoglycans | 1 | 2009 | 803 | 0.060 |
Why?
|
| Software | 1 | 2019 | 4433 | 0.060 |
Why?
|
| Radiation Protection | 1 | 2009 | 426 | 0.060 |
Why?
|
| Europe | 1 | 2012 | 3422 | 0.060 |
Why?
|
| Population Surveillance | 2 | 2012 | 2599 | 0.060 |
Why?
|
| Pulmonary Artery | 2 | 2009 | 1927 | 0.060 |
Why?
|
| Pulmonary Medicine | 1 | 2007 | 221 | 0.060 |
Why?
|
| Secondary Prevention | 1 | 2011 | 1472 | 0.060 |
Why?
|
| Time Factors | 4 | 2020 | 39953 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2019 | 17889 | 0.060 |
Why?
|
| Telemedicine | 1 | 2021 | 3051 | 0.060 |
Why?
|
| Travel | 1 | 2010 | 796 | 0.060 |
Why?
|
| Teleradiology | 1 | 2004 | 53 | 0.060 |
Why?
|
| Angiography | 1 | 2009 | 1597 | 0.060 |
Why?
|
| Hemorrhage | 1 | 2015 | 3422 | 0.050 |
Why?
|
| Genetic Linkage | 1 | 2009 | 2340 | 0.050 |
Why?
|
| Pelvis | 1 | 2008 | 734 | 0.050 |
Why?
|
| Transplantation | 1 | 2004 | 221 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2013 | 4060 | 0.050 |
Why?
|
| Sarcoma | 1 | 1994 | 1800 | 0.050 |
Why?
|
| Pathology, Clinical | 1 | 1986 | 376 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2021 | 64670 | 0.050 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2009 | 1004 | 0.050 |
Why?
|
| Mammography | 2 | 2003 | 2430 | 0.050 |
Why?
|
| Remote Consultation | 1 | 2004 | 237 | 0.050 |
Why?
|
| Photography | 1 | 2004 | 532 | 0.040 |
Why?
|
| Retrospective Studies | 7 | 2021 | 80673 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 3689 | 0.040 |
Why?
|
| Lower Extremity | 1 | 2008 | 1201 | 0.040 |
Why?
|
| Disease Progression | 1 | 2016 | 13506 | 0.040 |
Why?
|
| Adult | 17 | 2023 | 221083 | 0.040 |
Why?
|
| Rest | 2 | 2016 | 920 | 0.040 |
Why?
|
| Radiographic Image Enhancement | 1 | 2004 | 877 | 0.040 |
Why?
|
| Lung Transplantation | 1 | 2008 | 1307 | 0.040 |
Why?
|
| Deglutition | 1 | 2020 | 208 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2008 | 1304 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2014 | 3609 | 0.040 |
Why?
|
| Prognosis | 3 | 2018 | 29672 | 0.040 |
Why?
|
| Contrast Media | 2 | 2008 | 5311 | 0.040 |
Why?
|
| Hematologic Neoplasms | 1 | 2009 | 1895 | 0.040 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2004 | 830 | 0.040 |
Why?
|
| Forecasting | 1 | 2006 | 2928 | 0.030 |
Why?
|
| Logistic Models | 3 | 2017 | 13254 | 0.030 |
Why?
|
| Incidence | 3 | 2023 | 21357 | 0.030 |
Why?
|
| Neoplasms | 1 | 2004 | 22125 | 0.030 |
Why?
|
| Radiography, Interventional | 2 | 2015 | 1122 | 0.030 |
Why?
|
| ROC Curve | 2 | 2004 | 3582 | 0.030 |
Why?
|
| Safety | 2 | 2010 | 1151 | 0.030 |
Why?
|
| Cicatrix | 1 | 2000 | 793 | 0.030 |
Why?
|
| Hemangiopericytoma | 1 | 1994 | 71 | 0.030 |
Why?
|
| Oximetry | 1 | 2016 | 459 | 0.030 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 1994 | 64 | 0.030 |
Why?
|
| Postoperative Care | 2 | 2010 | 1469 | 0.030 |
Why?
|
| Pneumoconiosis | 1 | 1992 | 32 | 0.030 |
Why?
|
| Severity of Illness Index | 4 | 2016 | 15845 | 0.030 |
Why?
|
| Coal Mining | 1 | 1992 | 12 | 0.030 |
Why?
|
| Sensitivity and Specificity | 4 | 2009 | 14676 | 0.030 |
Why?
|
| Mucormycosis | 1 | 2014 | 103 | 0.030 |
Why?
|
| Silicosis | 1 | 1992 | 47 | 0.030 |
Why?
|
| Heart Failure | 1 | 2016 | 11701 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 15513 | 0.030 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 39121 | 0.030 |
Why?
|
| Fibrosarcoma | 1 | 1994 | 308 | 0.020 |
Why?
|
| Cystic Duct | 1 | 1991 | 18 | 0.020 |
Why?
|
| Reproducibility of Results | 5 | 2009 | 20120 | 0.020 |
Why?
|
| Costa Rica | 1 | 2011 | 180 | 0.020 |
Why?
|
| Risk | 1 | 2023 | 9614 | 0.020 |
Why?
|
| Mediastinum | 1 | 1992 | 267 | 0.020 |
Why?
|
| Quality of Life | 3 | 2021 | 13362 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 3419 | 0.020 |
Why?
|
| Artifacts | 1 | 2000 | 1913 | 0.020 |
Why?
|
| Adenocarcinoma | 2 | 2006 | 6340 | 0.020 |
Why?
|
| Algorithms | 2 | 2020 | 14023 | 0.020 |
Why?
|
| Pleura | 1 | 1992 | 244 | 0.020 |
Why?
|
| Liposarcoma | 1 | 1994 | 289 | 0.020 |
Why?
|
| Aneurysm | 1 | 1994 | 337 | 0.020 |
Why?
|
| Diaphragm | 1 | 1992 | 351 | 0.020 |
Why?
|
| Rhabdomyosarcoma | 1 | 1994 | 358 | 0.020 |
Why?
|
| Psychophysics | 1 | 2011 | 291 | 0.020 |
Why?
|
| Systems Integration | 1 | 2012 | 428 | 0.020 |
Why?
|
| Diagnosis, Differential | 3 | 2011 | 12975 | 0.020 |
Why?
|
| Central Venous Pressure | 1 | 2010 | 79 | 0.020 |
Why?
|
| Multiple Organ Failure | 1 | 1992 | 387 | 0.020 |
Why?
|
| Leiomyosarcoma | 1 | 1994 | 422 | 0.020 |
Why?
|
| Propensity Score | 1 | 2017 | 1913 | 0.020 |
Why?
|
| Gallbladder | 1 | 1991 | 308 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 763 | 0.020 |
Why?
|
| Aerospace Medicine | 1 | 2010 | 95 | 0.020 |
Why?
|
| Education | 1 | 2012 | 535 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2014 | 753 | 0.020 |
Why?
|
| Case-Control Studies | 3 | 2012 | 22157 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2014 | 1118 | 0.020 |
Why?
|
| Suction | 1 | 2010 | 266 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2014 | 858 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2000 | 3461 | 0.020 |
Why?
|
| Lod Score | 1 | 2009 | 600 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2022 | 7804 | 0.020 |
Why?
|
| Osteosarcoma | 1 | 1994 | 896 | 0.020 |
Why?
|
| Rubidium | 1 | 2007 | 121 | 0.020 |
Why?
|
| Lung Injury | 1 | 1992 | 422 | 0.020 |
Why?
|
| Iohexol | 1 | 2008 | 205 | 0.020 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2008 | 164 | 0.020 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2007 | 117 | 0.020 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2007 | 94 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2007 | 245 | 0.020 |
Why?
|
| Phenotype | 3 | 2011 | 16572 | 0.020 |
Why?
|
| Massachusetts | 2 | 2012 | 8836 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 5494 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2013 | 1984 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 6817 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6482 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2011 | 1685 | 0.020 |
Why?
|
| Total Lung Capacity | 1 | 2006 | 148 | 0.020 |
Why?
|
| Clinical Competence | 2 | 2012 | 4786 | 0.020 |
Why?
|
| Aneurysm, False | 1 | 2008 | 255 | 0.020 |
Why?
|
| Lung Volume Measurements | 1 | 2006 | 375 | 0.020 |
Why?
|
| Spirometry | 1 | 2009 | 928 | 0.020 |
Why?
|
| Haplotypes | 1 | 2011 | 2714 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2017 | 9648 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2011 | 989 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2001 | 9001 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2009 | 947 | 0.010 |
Why?
|
| Pulmonary Fibrosis | 1 | 1989 | 505 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 2007 | 651 | 0.010 |
Why?
|
| Florida | 1 | 1986 | 429 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 10213 | 0.010 |
Why?
|
| Delirium | 1 | 2016 | 1667 | 0.010 |
Why?
|
| Medical Oncology | 1 | 2016 | 2316 | 0.010 |
Why?
|
| Boston | 1 | 2017 | 9324 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2007 | 1157 | 0.010 |
Why?
|
| Vital Capacity | 1 | 2007 | 970 | 0.010 |
Why?
|
| Medical Informatics | 1 | 2011 | 733 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2010 | 2359 | 0.010 |
Why?
|
| Fibroadenoma | 1 | 2003 | 41 | 0.010 |
Why?
|
| Cisplatin | 1 | 2010 | 1651 | 0.010 |
Why?
|
| Siblings | 1 | 2007 | 824 | 0.010 |
Why?
|
| Laryngoscopy | 1 | 2009 | 707 | 0.010 |
Why?
|
| Data Compression | 1 | 2004 | 68 | 0.010 |
Why?
|
| Pressure | 1 | 2006 | 1152 | 0.010 |
Why?
|
| Carcinoma, Ductal | 1 | 2003 | 97 | 0.010 |
Why?
|
| Lasers | 1 | 2007 | 952 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12058 | 0.010 |
Why?
|
| Prevalence | 2 | 2012 | 15717 | 0.010 |
Why?
|
| Cytodiagnosis | 1 | 2006 | 447 | 0.010 |
Why?
|
| Electronic Mail | 1 | 2004 | 213 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 1780 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 14607 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 2007 | 1813 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2010 | 3512 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2007 | 1866 | 0.010 |
Why?
|
| Quality Control | 1 | 2004 | 834 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2011 | 15915 | 0.010 |
Why?
|
| World Health Organization | 1 | 2006 | 1321 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1989 | 2197 | 0.010 |
Why?
|
| Health Surveys | 1 | 2010 | 4036 | 0.010 |
Why?
|
| Biopsy | 1 | 2011 | 6781 | 0.010 |
Why?
|
| Equipment Design | 1 | 2007 | 3509 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 9278 | 0.010 |
Why?
|
| Gene Expression | 1 | 2011 | 7567 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2010 | 3923 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 2635 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 12983 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2003 | 20981 | 0.010 |
Why?
|
| Research Design | 1 | 2012 | 6178 | 0.010 |
Why?
|
| Oxygen | 1 | 2007 | 4226 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 26068 | 0.010 |
Why?
|
| Hospitalization | 1 | 1995 | 10712 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11066 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 12670 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 54419 | 0.010 |
Why?
|
| Technetium Tc 99m Lidofenin | 1 | 1991 | 3 | 0.010 |
Why?
|
| Imino Acids | 1 | 1991 | 19 | 0.010 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 1991 | 52 | 0.010 |
Why?
|
| Developing Countries | 1 | 2004 | 2862 | 0.010 |
Why?
|
| Organotechnetium Compounds | 1 | 1991 | 132 | 0.010 |
Why?
|
| Cholelithiasis | 1 | 1991 | 407 | 0.010 |
Why?
|
| AIDS-Related Complex | 1 | 1989 | 107 | 0.010 |
Why?
|
| Cholecystectomy | 1 | 1991 | 405 | 0.000 |
Why?
|
| Gallstones | 1 | 1991 | 284 | 0.000 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1991 | 508 | 0.000 |
Why?
|
| Radionuclide Imaging | 1 | 1991 | 1989 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 13630 | 0.000 |
Why?
|
| Models, Statistical | 1 | 2001 | 5077 | 0.000 |
Why?
|
| Animals | 2 | 2009 | 168083 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2008 | 41486 | 0.000 |
Why?
|
| Young Adult | 1 | 2009 | 59199 | 0.000 |
Why?
|
| Mice | 1 | 2009 | 81324 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1989 | 2603 | 0.000 |
Why?
|
| Heart Defects, Congenital | 1 | 1994 | 4673 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1989 | 42217 | 0.000 |
Why?
|
| Adolescent | 1 | 1994 | 88271 | 0.000 |
Why?
|